Schmertzler Michael: insider trades.
Schmertzler Michael reported 17 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 16 sales ($6.3M), across 2 companies.
- Transactions
- 17
- Purchases (P)
- 0
- Sales (S)
- 16
- Companies
- 2
- Name as filed
- SCHMERTZLER MICHAEL
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Ptc Therapeutics, Inc. (PTCT) | Director | 16 |
| Hamilton Lane INC (HLNE) | Director, TenPercentOwner | 1 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-17 | Ptc Therapeutics, Inc. | S | 376 | $68.45 | 1,296,594 | Form 4 |
| 2026-09-17 | Ptc Therapeutics, Inc. | S | 9,624 | $67.83 | 1,296,970 | Form 4 |
| 2026-09-16 | Hamilton Lane INC | A | 977 | $0 | 977 | Form 4 |
| 2026-09-16 | Ptc Therapeutics, Inc. | S | 2,994 | $66.58 | 1,313,600 | Form 4 |
| 2026-09-16 | Ptc Therapeutics, Inc. | S | 7,006 | $67.35 | 1,306,594 | Form 4 |
| 2026-09-10 | Ptc Therapeutics, Inc. | S | 10,000 | $67.34 | 1,316,594 | Form 4 |
| 2026-09-09 | Ptc Therapeutics, Inc. | S | 9,428 | $67.79 | 1,327,166 | Form 4 |
| 2026-09-09 | Ptc Therapeutics, Inc. | S | 572 | $68.67 | 1,326,594 | Form 4 |
| 2026-08-27 | Ptc Therapeutics, Inc. | S | 610 | $72.22 | 1,336,594 | Form 4 |
| 2026-08-27 | Ptc Therapeutics, Inc. | S | 11,890 | $71.55 | 1,337,204 | Form 4 |
| 2026-08-26 | Ptc Therapeutics, Inc. | S | 6,874 | $72.74 | 1,354,720 | Form 4 |
| 2026-08-26 | Ptc Therapeutics, Inc. | S | 5,626 | $73.18 | 1,349,094 | Form 4 |
| 2026-08-20 | Ptc Therapeutics, Inc. | S | 691 | $72.92 | 1,361,594 | Form 4 |
| 2026-08-20 | Ptc Therapeutics, Inc. | S | 2,390 | $71.88 | 1,362,285 | Form 4 |
| 2026-08-20 | Ptc Therapeutics, Inc. | S | 9,419 | $70.78 | 1,364,675 | Form 4 |
| 2026-08-19 | Ptc Therapeutics, Inc. | S | 5,335 | $72.86 | 1,381,259 | Form 4 |
| 2026-08-19 | Ptc Therapeutics, Inc. | S | 7,165 | $73.67 | 1,374,094 | Form 4 |
Questions
What stock did Schmertzler Michael buy or sell?
Schmertzler Michael reported 17 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 16 sales ($6.3M), across 2 companies.
Is Schmertzler Michael the same person as other filers with this name?
This page covers SEC CIK 1288952 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/schmertzler-michael-1288952.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.